ITPI970005A1 - OZONE USED FOR HAIR GROWTH - Google Patents
OZONE USED FOR HAIR GROWTH Download PDFInfo
- Publication number
- ITPI970005A1 ITPI970005A1 IT97PI000005A ITPI970005A ITPI970005A1 IT PI970005 A1 ITPI970005 A1 IT PI970005A1 IT 97PI000005 A IT97PI000005 A IT 97PI000005A IT PI970005 A ITPI970005 A IT PI970005A IT PI970005 A1 ITPI970005 A1 IT PI970005A1
- Authority
- IT
- Italy
- Prior art keywords
- hair
- ozone
- scalp
- ozone used
- hair growth
- Prior art date
Links
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 title claims description 13
- 230000003779 hair growth Effects 0.000 title description 2
- 210000004761 scalp Anatomy 0.000 claims description 10
- 201000004384 Alopecia Diseases 0.000 claims description 7
- 230000003676 hair loss Effects 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 5
- 230000003659 hair regrowth Effects 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 4
- 210000004209 hair Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 5
- 210000003780 hair follicle Anatomy 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000003625 skull Anatomy 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 206010003497 Asphyxia Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000304 vasodilatating effect Effects 0.000 description 2
- 208000035484 Cellulite Diseases 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- OGIIWTRTOXDWEH-UHFFFAOYSA-N [O].[O-][O+]=O Chemical compound [O].[O-][O+]=O OGIIWTRTOXDWEH-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
Ramo della tecnica: cosmesi. Branch of the technique: cosmetics.
DESCRIZIONE DESCRIPTION
La presente invenzione concerne 1?individuazione dell?attitudine dell?ozono a provocare la ricrescita dei capelli. The present invention relates to the identification of the aptitude of ozone to cause hair regrowth.
Descrizione sintetica dello stato della tecnica anteriore. Brief description of the state of the prior art.
Fino ad oggi, le sostanze utilizzate per limitare o rimediare alla caduta dei capelli sono essenzialmente i farmaci vasodilatanti: applicati in via topica, producono effetti di riattivazione del microcircolo del cuoio capelluto, determinando un nuovo afflusso di ossigeno e materiale nutritizio necessario per la rigenerazione del follicolo pilifero, dal quale dipende la produzione del capello. L'applicazione topica delle sostanze usate fino ad ora fa si che la capacit? di assorbimento cutaneo sia limitata e superficiale: ci? ? d?altronde inevitabile, poich?, se il farmaco vasodilatante venisse assorbito in maniera massiva, si potrebbero produrre effetti sistemici indesiderati. Until now, the substances used to limit or remedy hair loss are essentially vasodilating drugs: applied topically, they produce reactivation effects of the microcirculation of the scalp, determining a new influx of oxygen and nutritional material necessary for the regeneration of the hair. hair follicle, on which hair production depends. The topical application of the substances used up to now means that the capacity? of cutaneous absorption is limited and superficial: ci? ? on the other hand, it is inevitable, since, if the vasodilating drug were massively absorbed, undesirable systemic effects could be produced.
Obiettivo che ? invenzione intende raggiungere. Target what? invention intends to achieve.
L?invenzione qui descritta si propone di risolvere il problema della perdita dei capelli, fenomeno che interessa una larga fetta della popolazione (soprattutto maschile) e che viene considerato da una consistente percentuale delle persone un problema estetico che preferirebbero risolvere. The invention described here aims to solve the problem of hair loss, a phenomenon that affects a large portion of the population (especially men) and which is considered by a large percentage of people to be an aesthetic problem that they would prefer to solve.
Il prodotto qui descritto risulta idoneo a stimolare la crescita naturale dei capelli ristabilendo un valido microcircolo a livello del cuoio capelluto, senza produrre alcun effetto sistemico. The product described here is suitable for stimulating natural hair growth by re-establishing a valid microcirculation in the scalp, without producing any systemic effect.
L?invenzione si basa su due considerazioni principali. The invention is based on two main considerations.
In primo luogo, la perdita dei capelli presuppone l?alterazione del microcircolo del cuoio capelluto. La sua progressiva atrofia determina la perdita della funzione del follicolo pilifero che, a poco a poco, non ? pi? in grado di generare il capello. Come qualsiasi tessuto che lentamente va in atrofia, il follicolo, non pi? sopportato dal microcircolo (e quindi da ossigeno e sostanze nutritizie), produce dapprima un capello fragile e facilmente staccabile dalla radice. Lo stadio successivo comporta la spontanea caduta del capello e rimpossibilit? della sua rigenerazione. First of all, hair loss presupposes the alteration of the microcirculation of the scalp. Its progressive atrophy determines the loss of function of the hair follicle which, little by little, does not? pi? able to generate the hair. Like any tissue that slowly atrophies, the follicle, no longer? supported by the microcirculation (and therefore by oxygen and nutrients), it first produces a fragile hair that is easily detachable from the root. The next stage involves the spontaneous loss of the hair and re-possibility? of its regeneration.
In secondo luogo, se il cuoio capelluto viene, per qualsiasi ragione, ad aderire strettamente alla teca cranica, il capello non riesce a ricrescere a causa del correlato ?soffocamento? del follicolo. Secondly, if the scalp comes, for whatever reason, to adhere closely to the skull, the hair is unable to grow back due to the related? Suffocation? of the follicle.
Da queste considerazioni ? nata l?idea utilizzare l?ozono al fine di riattivare un processo ?dimenticato? di produzione del capello da parte del follicolo pilifero e d? ristabilire una valido spazio tra la volta ossea e il cuoio capelluto di modo da permettere un maggior ?respiro? dei follicoli. From these considerations? the idea was born to use ozone in order to reactivate a process? forgotten? of production of the hair by the hair follicle and d? re-establish a valid space between the bone vault and the scalp in order to allow a greater? breath? of the follicles.
Questi effetti derivano dalle propriet? dell'ozono, che, anche se usato in dosi omeopatiche, ha capacit? rigenerative, cicatriziali e soprattutto di stimolo alla rigenerazione vascolo-nervosa. These effects derive from the properties? of ozone, which, even if used in homeopathic doses, has the capacity? regenerative, cicatricial and above all to stimulate vascular-nervous regeneration.
Si deve considerare inoltre che l'ozono (03), essendo un allotropo dell'ossigeno, ? molto instabile ed ha quindi un'emivita brevissima, trasformandosi in circa un secondo nella sua forma pi? stabile, cio? l?ossigeno (02). L'estrema labilit? della sostanza impedisce che si abbiano effetti sistemici di qualsiasi tipo: non sono perci? possibili effetti collaterali, n? allergici (trattandosi di ossigeno). Per gli stessi motivi non vi possono essere controindicazioni. It must also be considered that ozone (03), being an allotrope of oxygen,? very unstable and therefore has a very short half-life, transforming in about a second into its pi? stable, that is? oxygen (02). The extreme lability? of the substance prevents systemic effects of any kind from occurring: aren't they therefore? possible side effects, n? allergic (being oxygen). For the same reasons there can be no contraindications.
Il prodotto qui descritto ? naturale e permette inoltre di non avere limiti intrinseci al numero di applicazioni, potendosi cosi adattare alle reali esigenze del singolo soggetto trattato. The product described here? natural and also allows to have no intrinsic limits to the number of applications, thus being able to adapt to the real needs of the individual treated subject.
L?uso dell?ozono ? diffuso particolarmente in Germania, in Svizzera, nell'Europa Orientale e a Cuba. Fino ad ora l?ozono ? stato utilizzato in estetica (per la cura della cellulite e delle teleangectasie) e in medicina (per patologie epatiche, artrosiche, autoimmuni, infettive, degenerative, circolatorie e per la cura deH?ernia discale). Inoltre, viene impiegato nell'industria per la disinfezione delle acque (potabilizzazione o trattamento delle acque reflue) e la neutralizzazione dei gas di scarico industriali contenenti solfato. The use of ozone? particularly widespread in Germany, Switzerland, Eastern Europe and Cuba. Until now ozone? it has been used in aesthetics (for the treatment of cellulite and telangiectasias) and in medicine (for hepatic, arthritic, autoimmune, infectious, degenerative, circulatory diseases and for the treatment of disc herniation). Furthermore, it is used in industry for the disinfection of water (potabilization or wastewater treatment) and the neutralization of industrial waste gases containing sulphate.
Non risulta che l?ozono venga utilizzato per rimediare al problema della perdita dei capelli. There is no evidence that ozone is used to remedy the problem of hair loss.
Analisi dell invenzione Analysis of the invention
L?ozono, in considerazioni delle sue propriet?, presenta l?attitudine a provocare la ricrescita naturale dei capelli e a prevenirne la successiva ri-caduta. Affinch? produca effetti, esso deve essere fatto penetrare nel cuoio capelluto, determinando cos? la rigenerazione del follicolo pilifero e agevolando il distacco tra la volta ossea e il cuoio capelluto, distacco che evita il ?soffocamento? del follicolo. Ozone, in consideration of its properties, has the ability to cause the natural regrowth of the hair and to prevent its subsequent re-fall. So that? produce effects, it must be made to penetrate the scalp, thus determining? the regeneration of the hair follicle and facilitating the detachment between the bone vault and the scalp, detachment that avoids the? suffocation? of the follicle.
L?introduzione dell?ozono pu? avvenire attraverso iniezioni di una miscela di ossigenoozono oppure attraverso sostanze topiche capaci di penetrare fino al cuoio capelluto. La quantit? di ozono applicato e la frequenza delle iniezioni o delle applicazioni in via topica variano in funzione dell?estensione della calvizie e della reattivit? del soggetto al prodotto. The introduction of ozone can take place through injections of a mixture of oxygen ozone or through topical substances capable of penetrating up to the scalp. The quantity of applied ozone and the frequency of injections or topical applications vary according to the extent of baldness and reactivity? of the subject to the product.
Per ottenere effetti soddisfacenti, ? necessaria una successione di iniezioni o applicazioni. To obtain satisfactory effects,? a succession of injections or applications is required.
Le caratteristiche ed i vantaggi del prodotto qui descritto sono ulteriormente evidenziati mediante un esempio di utilizzazione del suddetto prodotto, esempio fornito a titolo illustrativo e non limitativo. The characteristics and advantages of the product described herein are further highlighted by means of an example of use of the aforesaid product, an example provided for illustrative and non-limiting purposes.
Su un soggetto con calvizie estesa per circa P80% de! cranio, si ? proceduto ad iniettare in una prima seduta, con un ago di 2 cm., 27 G, una quantit? di 5 cc. di 02-03 alla concentrazione di 2 microgrammi Cb/ml.C^. On a subject with extensive baldness for about P80% of! skull, yes? proceeded to inject in a first session, with a needle of 2 cm., 27 G, a quantity? of 5 cc. of 02-03 at a concentration of 2 micrograms Cb / ml. C ^.
Dato che il gas non si diffondeva spontaneamente (a causa dell? adesione del cuoio capelluto alla teca cranica), si ? proceduto ad altre due iniezioni (con gli stessi parametri) in punti distinti del cranio. Since the gas did not spread spontaneously (due to the adhesion of the scalp to the cranial theca), yes? proceeded to two more injections (with the same parameters) in different points of the skull.
Dopo l?iniezione, ? stato effettuato un massaggio delicato per favorire la distribuzione del gas sull?intera superficie della volta cranica. After the injection,? A gentle massage was performed to facilitate the distribution of gas over the entire surface of the cranial vault.
Successivamente, sono state effettuate sedute di inoculazione con la seguente frequenza: per le prime cinque settimane, due volte a settimana; per i successivi due mesi, una volta alla settimana. Subsequently, inoculation sessions were performed with the following frequency: for the first five weeks, twice a week; for the next two months, once a week.
All?ottava seduta la concentrazione ? stata portata a 6 microgrammi O3/1T1I.O2 e la quantit? totale iniettata a 40 cc. Concentration in the eighth session? been brought to 6 micrograms O3 / 1T1I.O2 and the quantity? total injected at 40 cc.
In ogni seduta ? stato effettuato il delicato massaggio sopra descritto. In every session? the delicate massage described above was performed.
Dopo circa un mese e mezzo di trattamento, il processo di ricrescita dei capelli ? apparso evidente ad occhio nudo. In particolare, si ? verificata una ricrescita dapprima alquanto rada e successivamente sempre pi? fitta, tanto che dopo circa tre mesi dall?inizio del trattamento, si ? constatata una ricrescita estesa al 70% della volta, con capelli fitti e robusti. After about a month and a half of treatment, the hair regrowth process? appeared evident to the naked eye. In particular, yes? verified a regrowth at first somewhat sparse and subsequently more and more? dense, so much so that after about three months from the start of treatment, yes? noted a regrowth extended to 70% of the time, with thick and robust hair.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97PI000005A ITPI970005A1 (en) | 1997-01-28 | 1997-01-28 | OZONE USED FOR HAIR GROWTH |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97PI000005A ITPI970005A1 (en) | 1997-01-28 | 1997-01-28 | OZONE USED FOR HAIR GROWTH |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITPI970005A0 ITPI970005A0 (en) | 1997-01-28 |
| ITPI970005A1 true ITPI970005A1 (en) | 1998-07-28 |
Family
ID=11394067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT97PI000005A ITPI970005A1 (en) | 1997-01-28 | 1997-01-28 | OZONE USED FOR HAIR GROWTH |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | ITPI970005A1 (en) |
-
1997
- 1997-01-28 IT IT97PI000005A patent/ITPI970005A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ITPI970005A0 (en) | 1997-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY107088A (en) | Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof | |
| ATE421318T1 (en) | DOSAGE FORM WHICH EXHIBITS RAPID DISPERSION PROPERTIES, METHOD OF APPLICATION AND METHOD FOR THE PRODUCTION OF THE SAME | |
| FI973468L (en) | Method for manufacturing preparations for use in teeth whitening or in the treatment of skin and mucous membrane diseases | |
| GB2188060B (en) | Aqueous delayed-foaming cosmetic composition for hair and skin treatment | |
| DE69512685D1 (en) | AGENTS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES TO OR THROUGH THE SKIN | |
| HUP0102337A2 (en) | Process for preparation of compositions for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear | |
| JPH04506654A (en) | Nail, skin and hair protection reagents | |
| ATE231882T1 (en) | 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THESE 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES AND THEIR USE FOR THE PRODUCTION OF MEDICINAL PRODUCTS | |
| ES2102921T3 (en) | USE OF DERIVATIVES OF THE STIMULATING HORMONE OF ALPHA-TYPE MELANOCITES TO STIMULATE HAIR GROWTH. | |
| AU4152989A (en) | Process for preparing cleansing emulsions for beauty treatment and so obtained cosmetic products | |
| DE69628296D1 (en) | USE OF SOPHOROLIPIDES FOR THE PRODUCTION OF COSMETIC PRODUCTS, IN PARTICULAR FOR THE TREATMENT OF THE SKIN | |
| GB2143434B (en) | Hair-care composition and hair treatment process | |
| ATE332146T1 (en) | PHARMACEUTICAL PREPARATION CONTAINING PYROGENIC SILICON DIOXIDE OF HIGH PAMPED DENSITY | |
| US3119398A (en) | Hair structure, process of making same and method for implanting hair in scalp | |
| HUP9900511A2 (en) | Use of at least one beta-adrenergic agonist as a p substance antagonist and process for cosmetical treating | |
| IL114296A (en) | Use of melatonin in the manufacture of medicament for treating or preventing addiction to benzodiazepines pharmaceutical formulation for this purpose and process for making the formulation | |
| DE69823045T2 (en) | INNOVATIVE FORMULATION FOR INHALATION WITH A BULK DENSITY BETWEEN 0.28 AND 0.38 G / ML, WITH TERBUTALINSULPHATE, METHOD FOR PRODUCING THE FORMULATION AND ITS APPLICATION THEREOF | |
| BR9302646A (en) | COSMETICALLY ACCEPTABLE COMPOSITION, SUITABLE FOR TOPICAL APPLICATION TO SKIN, HAIR OR NAILS, AND PROCESS FOR SUCH TREATMENT | |
| ATE201136T1 (en) | MEDICINAL FORM FOR DELIVERING COLLAGENASE TO WOUNDS AND METHOD FOR PRODUCING SAME | |
| CA2371676A1 (en) | Fingernail hardening treatment | |
| ITPI970006A1 (en) | OXYGEN-OZONE-BASED HAIR GROWTH METHOD | |
| ATE91230T1 (en) | PRODUCTS FOR NAIL, SKIN AND HAIR CARE. | |
| GR3034886T3 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them | |
| FR2612774B1 (en) | COSMETIC AND PHARMACEUTICAL COMPOSITIONS USED TO TREAT THE PROCESS OF ANDROGENOGENETIC ALOPECIA, CONTAINING AZELAIC ACID | |
| JPH1192339A (en) | Hair restoration / hair restoration |